Sigma Planning Corp’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,985	Closed	-$209K	–	1332
2025 Q1	$209K	Sell	16,985 -800	-4%	-$11.3K	0.01%	1114
2024 Q4	$235K	Sell	17,785 -950	-5%	-$16.3K	0.01%	1024
2024 Q3	$361K	Sell	18,735 -200	-1%	-$4.13K	0.01%	880
2024 Q2	$389K	Sell	18,935 -900	-5%	-$18.8K	0.01%	824
2024 Q1	$472K	Buy	+19,835	New	+$442K	0.01%	788
2023 Q4	–	Sell	-20,750	Closed	-$301K	–	1129
2023 Q3	$301K	Sell	20,750 -10	-0%	-$189	0.01%	920
2023 Q2	$435K	Sell	20,760 -2,490	-11%	-$51.8K	0.02%	788
2023 Q1	$491K	Sell	23,250 -2,690	-10%	-$66.9K	0.02%	798
2022 Q4	$660K	Buy	25,940 +300	+1%	+$7K	0.02%	652
2022 Q3	$616K	Buy	25,640 +1,800	+8%	+$40.4K	0.02%	649
2022 Q2	$459K	Sell	23,840 -750	-3%	-$12.5K	0.02%	792
2022 Q1	$427K	Hold	24,590	–	–	0.01%	904
2021 Q4	$538K	Sell	24,590 -200	-0.8%	-$3.69K	0.02%	821
2021 Q3	$474K	Sell	24,790 -450	-2%	-$7.5K	0.01%	848
2021 Q2	$433K	Sell	25,240 -200	-0.8%	-$3.66K	0.01%	895
2021 Q1	$569K	Sell	25,440 -85	-0.3%	-$1.92K	0.02%	717
2020 Q4	$568K	Sell	25,525 -600	-2%	-$12.4K	0.02%	648
2020 Q3	$386K	Buy	26,125 +100	+0.4%	+$1.52K	0.02%	699
2020 Q2	$386K	Buy	+26,025	New	+$396K	0.02%	689
2019 Q3	–	Sell	-12,280	Closed	-$114K	–	1058
2019 Q2	$114K	Buy	+12,280	New	+$89.5K	0.01%	949